Jing Zhou is a Senior Principal Scientist and Group Leader at Pfizer since August 2023, previously serving as Director at Codiak BioSciences from October 2020 to September 2023, specializing in molecular and cellular biology with expertise in platform development, cell line engineering, assay development, and genome editing. Prior experience includes roles at Dana-Farber Cancer Institute from January 2012 to October 2020, where Jing Zhou progressed from Biology Scientist/Project Leader in the Center for Protein Degradation to Associate Director and Senior Scientist, focusing on protein degradation, drug screening, and candidate evaluation. Earlier positions involved research in cancer biology, particularly studying brain tumors and BMP signaling pathways. Jing Zhou holds a PhD in Biomedical Sciences from UT Southwestern Medical Center, an MPhil in Biology from The Hong Kong University of Science and Technology, and a Bachelor's degree in Biophysics from Fudan University.
This person is not in any teams
This person is not in any offices